FDA to decide on pixantrone in April

Seattle-based pharmaceutical company Cell Therapeutics (CTI) announced Tuesday that the US Food & Drug Administration will make a final decision on whether or not to give market approval to CTI's oncology product pixantrone (Pixurvi) by April 24, 2012.

Last year the FDA chose to reject pixantrone after an oncology panel unanimously recommended that the FDA do just that. The rejection came on the heels of a poorly executed pivotal Phase III trial of the drug and the unconvincing data. Instead of completing a new trial, CTI appealed the FDA's decision. And it is this appeal that the FDA will be answering in April.

CTI will learn whether pixantrone receives market approval in Europe next month.

CTI has pushed pixantrone first as a third-line therapy for non-Hodgkin's lymphoma patients who have failed two prior therapies, then as a second-to-fourth line therapy for the same indication.

Source: Boston Globe

More Articles

More Articles

This entry looks at what is sometimes referred to as mesenteric lymphoma, also referred to as non-Hodgkin's...

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

B cell lymphoma is not one disease but a few dozen heterogeneous diseases, or individual cancers, that affect the b...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Also known as Hodgkin's disease, Hodgkin's lymphoma (HL) is a cancer of the white blood cells, or...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

It's not uncommon for patients with some lymphomas to experience itching (clinically known as pruritus). Lymphoma itching symptoms can range from...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...